Drug Approvals
🇺🇸 FDA Page 27FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.
Showing 313–324 of 665 articles
Reforming PEPFAR: Insights from Former CDC Directors
BioMarin's SWOT Analysis: Competitive Challenges Ahead
Eli Lilly and Verve's Gene Editor: A Breakthrough in Cholesterol Management
FDA Approves Expanded Access for Daraxonrasib in Pancreatic Cancer
Liminatus Pharma to Merge with InnocsAI: A Market Analysis
FDA Drug Approval Decisions Expected in May 2026: What to Anticipate
The Perimenopause Movement: A Double-Edged Sword for Women
Designing a Future-Ready Tech Roadmap for Emerging Pharma
Biogen and Denali's Parkinson's Drug Trial: What Went Wrong?
Medicaid Funding Cuts: Implications for Pharma Providers
FDA Approval for Datroway: Implications for Breast Cancer Treatment
FDA Approves 17 Drugs with Continuous Manufacturing: Implications for Pharma